SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union

1 week ago 9
ARTICLE AD BOX
Read Entire Article
  1. Homepage
  2. Finance
  3. SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union

Related

Iran, US to resume nuclear talks amid clashing red lines

Iran, US to resume nuclear talks amid clashing red lines

2 hours ago 0
Genius Group CEO, Roger Hamilton's X Account Hacked

Genius Group CEO, Roger Hamilton's X Account Hacked

3 hours ago 1
China's car sales rise 14.8% in April

China's car sales rise 14.8% in April

4 hours ago 1
RIGHT SIDEBAR TOP AD

Trending

1. mariners score
2. sean connery
3. mason graham
4. zhang weili
5. bandersnatch
6. vanda pharmaceuticals
7. día de la madre
8. ufc
9. mariners game
10. amanda nunes

Popular

What we know about the New York City helicopter crash that killed 6 people

What we know about the New York City helicopter crash that k...

4 weeks ago 128
Paxton's challenge isn't the only one worrying Senate Republicans

Paxton's challenge isn't the only one worrying Senate Republ...

4 weeks ago 103
Stanford 2025 AI Index Reveals Surge in Adoption, Investment, and Global Impact as Trust and Regulation Lag Behind

Stanford 2025 AI Index Reveals Surge in Adoption, Investment...

1 month ago 88
Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds slim Masters lead at midway point

Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds sli...

4 weeks ago 87
Bitcoin Slips With XRP, ADA as Nvidia's Massive $5.5B Charge Sours Investor Sentiment

Bitcoin Slips With XRP, ADA as Nvidia's Massive $5.5B Charge...

3 weeks ago 86
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Powerbits - breaking news today 2025. All rights are reserved